#United States #Financial Growth #healthcare management #Astrana Health #Alhambra

Astrana Health, Inc. Reports Remarkable Financial Results for 2025

Astrana Health, Inc. (NASDAQ: ASTH), a prominent technology-driven healthcare management company, has recently disclosed its exceptional financial results for the year ending December 31, 2025. With a commitment to enhancing patient care through innovative solutions, Astrana has achieved record levels in revenue, adjusted EBITDA, and free cash flow, signaling a strong position in the healthcare sector that focuses on physician-centric services.

Key Financial Highlights

In a notable announcement, Brandon Sim, President and CEO, stated, “Astrana delivered record revenue, adjusted EBITDA, and free cash flow in 2025, demonstrating the strength and predictability of our fully delegated, payer-agnostic care model and AI-enabled technology platform.” The company reported total revenue of $3,181.8 million, marking an impressive 56% increase from the previous year. The Care Partners revenue alone saw a surge, reaching $3,022.6 million, up 55% year-over-year.

Adjusted EBITDA for the year stood at $205.4 million, which also represents a 21% increase from $170.4 million in 2024. This financial success has been coupled with a recorded net income of $22.5 million, resulting in a diluted earnings per share (EPS) of $0.46.

Fourth Quarter Performance

The fourth quarter of 2025 showcased a continuation of positive trends, with total revenue reaching $950.5 million, a 43% increase from $665.2 million year-over-year. Care Partners revenue for this quarter escalated to $892.5 million, a 38% increase, showcasing the efficacy of Astrana’s business model even in challenging operating conditions. Net income for Q4 was reported at $6.0 million, yielding a diluted EPS of $0.12. The adjusted EBITDA for the fourth quarter was $52.5 million, signifying a robust 50% increase compared to $35 million in the same period the year before.

Strategic Growth and Future Outlook

Looking ahead into 2026, Astrana Health is optimistic regarding its growth trajectory, projecting around 24% revenue growth and 29% adjusted EBITDA growth at the midpoint. With the integration of Prospect Health ahead of schedule, Astrana remains focused on its commitment to providing high-quality, value-based care across its network.

Major Developments and Initiatives

In addition to impressive financial outcomes, Astrana Health's Board of Directors increased the maximum limit for its stock repurchase program from $50 million to $100 million. This move underscores confidence in the company's stock value and its sustained commitment to enhancing shareholder value.

Furthermore, despite some challenges in internal control as it prepares to submit its annual report for 2025, the company reassured that these issues do not indicate any material misstatement in its financial results. Targeted investments are being made in the organization to address these matters efficiently.

“Building a system that prioritizes patient outcomes, greater access to care, and cost efficiency is at the heart of Astrana Health’s mission. By empowering healthcare providers with the right technology and support, we aim to transform the healthcare landscape,” stated Sim.

Astrana Health continues to strive for excellence, actively managing more than 20,000 providers and over 1.6 million patients, aiming to ensure that every individual can experience the healthcare system they deserve. Seizing opportunities in a dynamic healthcare environment while enhancing detailed financial stewardship, Astrana Health, Inc. is well on its way to redefining patient-centric care and delivering superior results.